Work

Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML.

Year: 2004

Type: article

Source: Blood

DOI: 10.1182/blood.v104.11.454.454

Authors: F. Heidel, F. Breitenbuecher, T. Kindler, F. K. Solem, B. Carius, H.-M. Thiede, P. S. Cohen, J. Roesel, E. H. Estey, E. Feldman, G. Ehninger, G. J. Schiller, V. Klimek, S. Nimer, D. DeAngelo, F. Giles, R. M. Stone, C. Huber, T. Fischer

Institutions: Johannes Gutenberg University Mainz, Novartis (Switzerland), The University of Texas MD Anderson Cancer Center, Cornell University, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2531032042

FWCI: 0.848

Cites:

Cited by: 7

Related to: 10